
|Articles|July 1, 2002
Drug delivery devices useful for posterior segment diseases
Author(s)Julia Talsma
Durham, NC-Sustained-release drug delivery systems are a promising new approach for treating posterior segment diseases, according to Glenn J. Jaffe, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5














































.png)


